the estimated duration of the steroid treatment. Mild hyperglycemia in an immunocompetent patient may not require treatment if the steroids will be discontinued in a week or two. Moderate hyperglycemia carries an increased risk of infection, especially fungal, and especially in people with other risk factors such as immunocompromise or central intravenous lines. Insulin is the most common treatment. Further reading Fresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directions, Nature Reviews Endocrinology volume 18, pages540–557 (2022) Steroid-Induced Diabetes Mellitus and Related Risk Factors in Patients With Neurologic Disease - MedScape Diabetes